SV
C
US

CVS.US · CVS HEALTH Corp

US · US

Latest price82.00 USD
30D+8.08%
Vs. base value+32.4%

Research summary

CVS.US latest organized financial period shows revenue grew +7.85% YoY and net income declined -61.68% YoY. Current price is about 82 USD, while the model base case is about 61.92 USD; the current price sits +32.4% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.

Key financial trend

Annual financial metrics with switchable views. · Unit: USD

13 records
Revenue402B USD
Net income2B USD
Free cash flow8B USD
Operating cash flow11B USD

Price trend

Price date: 2026/04/29 · Updated: 2026/04/29 15:26

Valuation model range

Hover each model row to inspect formulas and inputs.

Current price82.00 USD
Base value61.92 USD
Vs. base+32.4%
Price date2026/04/29
61.92 USD61.92 USD61.92 USD

+32.43%

Calculated

DCF

Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.

77.22 USD72.18 USD90.50 USD

+13.6%

72.18 USDCurrent price is 13.6% above the base model value.
Calculated

Owner Earnings

Uses recent net income as an owner-earnings proxy and discounts scenario growth.

48.55 USD45.38 USD56.90 USD

+80.7%

45.38 USDCurrent price is 80.7% above the base model value.Adjusted reference: 52.09 USD
Calculated

Reverse DCF

Solves the forward FCF growth rate implied by the current price.

Implied growth-0.3%

Current price implies roughly -0.3% annualized FCF growth.

-0.3%Current price implies roughly -0.3% annualized FCF growth.
Calculated

Earnings Power Value

Estimates earnings power value without assuming growth.

61.92 USD61.92 USD61.92 USD

+32.43%

61.92 USDCurrent price is 32.4% above the base model value.

Updated: 2026/04/29 15:26

Valuation basis and non-recurring items

Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.

Expand

A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.

PeriodItemCategoryAfter-tax impactConfidence
2025/12/31Business sale gain/lossAsset sale gain/loss-186M USDMedium
2025/12/31Integration and restructuring costsRestructuring-92M USDMedium
2024/12/31Integration and restructuring costsRestructuring-384M USDMedium
2023/12/31Asset impairmentImpairment-360M USDMedium
2023/12/31Integration and restructuring costsRestructuring-1B USDMedium
2022/12/31Other special chargesOther-5B USDMedium
2022/12/31Special income/chargesOther-7B USDMedium
2021/12/31Other special chargesOther-357M USDMedium
2025/09/30Business sale gain/lossAsset sale gain/loss-186M USDMedium
2025/09/30Integration and restructuring costsRestructuring-100M USDMedium
2025/06/30Business sale gain/lossAsset sale gain/loss-186M USDMedium
2025/06/30Integration and restructuring costsRestructuring-80M USDMedium
2025/03/31Business sale gain/lossAsset sale gain/loss-186M USDMedium
2025/03/31Integration and restructuring costsRestructuring-36M USDMedium
2024/09/30Asset impairmentImpairment-664M USDMedium
2024/09/30Integration and restructuring costsRestructuring-386M USDMedium
2024/06/30Integration and restructuring costsRestructuring-417M USDMedium
2024/03/31Integration and restructuring costsRestructuring-95M USDMedium
Ad placement

Quarterly and annual financial table

Financial DetailsShowing latest 5 / 13
PeriodTypeRevenueNet IncomeAdjusted net incomeFree Cash FlowDiluted EPSAdjusted EPS
2025/12/31Annual402B USD2B USD2B USD8B USD1.391.61
2024/12/31Annual373B USD5B USD5B USD6B USD3.663.96
2023/12/31Annual358B USD8B USD10B USD10B USD6.477.64
2022/12/31Annual322B USD4B USD15B USD13B USD3.2611.71
2021/12/31Annual------
Ad placement